ASB Consultores LLC Lowers Position in CME Group Inc. (NASDAQ:CME)

ASB Consultores LLC decreased its stake in shares of CME Group Inc. (NASDAQ:CME) by 51.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,276 shares of the financial services provider’s stock after selling 1,328 shares during the period. ASB Consultores LLC’s holdings in CME Group were worth $251,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Gold Investment Management Ltd. purchased a new stake in CME Group in the fourth quarter worth $26,000. Salomon & Ludwin LLC purchased a new stake in CME Group in the 1st quarter worth about $28,000. Y.D. More Investments Ltd bought a new stake in CME Group in the 2nd quarter valued at about $36,000. McClarren Financial Advisors Inc. lifted its holdings in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the last quarter. Finally, Asset Dedication LLC boosted its position in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 0.7 %

NASDAQ:CME opened at $213.16 on Friday. The company has a 50 day simple moving average of $207.86 and a two-hundred day simple moving average of $207.53. The company has a market cap of $76.75 billion, a PE ratio of 24.25, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the business posted $2.30 earnings per share. The firm’s quarterly revenue was up 12.7% compared to the same quarter last year. Research analysts forecast that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.16%. CME Group’s payout ratio is 52.33%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on CME shares. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Piper Sandler reiterated an “overweight” rating and issued a $225.00 price target on shares of CME Group in a research report on Tuesday, August 20th. Barclays boosted their price objective on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research note on Thursday, July 25th. Bank of America downgraded CME Group from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Finally, Deutsche Bank Aktiengesellschaft upped their price target on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus price target of $209.73.

Insiders Place Their Bets

In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.